ICE Pharma, a global specialist in bile acids and their derivatives, will showcase its portfolio and integrated capabilities at CPHI Milan 2026, taking place from 6–8 October 2026. Visitors can meet the ICE Pharma team at Booth 2A18.
With more than 70 years of expertise in bile acid chemistry, development and manufacturing, ICE Pharma supports customers across the pharmaceutical and healthcare value chain. At CPHI Milan, the company will highlight four key areas: active pharmaceutical ingredients (APIs), functional excipients, CDMO services for finished dosage forms (FDFs) and nutraceutical solutions.
Our experience in bile acids has enabled us to develop a broad portfolio that supports innovation across pharmaceuticals and healthcare
The company’s portfolio includes Ursodeoxycholic Acid (UDCA) and other specialised bile acid derivatives, as well as functional excipients for formulation and drug delivery applications. Through its integrated capabilities and the expertise of ABC Farmaceutici, ICE Pharma also supports pharmaceutical partners with development and manufacturing services for solid and liquid finished dosage forms.
At ICE Pharma, we can support customers across multiple stages of their development journey
In addition, ICE Pharma is expanding its nutraceutical offering, leveraging its expertise in bile acids and their role in areas including digestion, metabolism and the gut microbiome.
“At ICE Pharma, our strength is built on scientific expertise, consistent quality and integrated manufacturing capabilities,” said Agostino Barazza, Chief Executive Officer of ICE Pharma. “Our experience in bile acids has enabled us to develop a broad portfolio that supports innovation across pharmaceuticals and healthcare.”
Dr. Roger Viney, Chief Commercial Officer of ICE Pharma, added: “Customers are increasingly looking for partners who can offer expertise and solutions beyond a single product. At ICE Pharma, we can support customers across multiple stages of their development journey — from specialised APIs and functional excipients to finished dosage forms, CDMO services and nutraceutical solutions.”
Visitors to Booth 2A18 can meet ICE Pharma experts and discuss potential collaborations across the company’s portfolio and capabilities.
To arrange a meeting, contact sales@icepharma.com.
